The global Prostate Specific Antigen market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Prostate Specific Antigen volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prostate Specific Antigen market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Prostate Specific Antigen in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Prostate Specific Antigen manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Advaxis, Inc.
Aeterna Zentaris Inc.
Bavarian Nordic A/S
Curevac AG
GenSpera, Inc.
Inovio Pharmaceuticals, Inc.
OncBioMune Pharmaceuticals Inc.
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
G-115
INO-5150
ADXS-PSA
AEZS-120
Others

Segment by Application
Prostate Cancer
Metastatic Hormone Refractory Prostate Cancer
Others